| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.60B | +2.6% |
| R&D Expense | $1.20B | +9.1% |
| SG&A Expense | $3.87B | +7.7% |
| Operating Income | $3.60B | -36.3% |
| Interest Expense | $506.0M | -9.0% |
| Pre-tax Income | $5.84B | -34.7% |
| Income Tax | $940.0M | -51.4% |
| Net Income | $4.90B | -30.1% |
| EPS (Basic) | $31.61 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.58B | -27.0% |
| Accounts Receivable | $1.51B | +3.0% |
| Inventory | $978.0M | +20.6% |
| Current Assets | $12.49B | +0.5% |
| Total Assets | $43.76B | +2.8% |
| Current Liabilities | $11.59B | +21.6% |
| Long-term Debt | $12.88B | +0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.90B | -18.7% |
| Capital Expenditures | $1.44B | +1.4% |
| Investing Cash Flow | -$1.24B | -160.3% |
| Financing Cash Flow | -$2.61B | +62.7% |
| Free Cash Flow | $1.47B | -31.9% |
| -27.7% |
| EPS (Diluted) | $31.47 | -27.7% |
| Total Liabilities |
| $28.44B |
| -4.1% |
| Stockholders' Equity | $15.31B | +18.5% |